MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2018 International Congress

    Trust the Patient not the Doctor: Health-related Quality of Life in Cervical Dystonia

    M. Al Hussona, J. Dover, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: Assess measures on health-related quality-of-life, and anxiety and depression in patients with cervical dystonia attending University Hospital specialist clinic. Background: Non-motor symptoms are a…
  • 2018 International Congress

    Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka

    A. Keshavaraj, S. Kunathilagam (Jaffna, Sri Lanka)

    Objective: To evaluate motor and non-motor domains, as well as for demographic and disease related characteristics of patients with Parkinson’s disease and the relations with…
  • 2018 International Congress

    Non-motor outcomes of subthalamic DBS in PD depend on the location of volume of activated tissue

    JN. Petry-Schmelzer, H. Dafsari, M. Krause, T. Dembek, A. Keyoumars, A. Rizos, M. Silverdale, J. Evans, M. Barbe, G. Fink, P. Martinez-Martin, V. Visser-Vandewalle, A. Antonini, L. Timmermann, K. Ray-Chaudhuri (Cologne, Germany)

    Objective: To investigate the impact of stimulation location on non-motor symptoms (NMS) in PD patients with DBS in the subthalamic nucleus (STN) via an analysis…
  • 2018 International Congress

    Stigma and communication in people with Parkinson’s disease (PPD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: To present results about stigma in PPD from a Parkinson’s Workshop. These are preliminary results in the path to address the main project question…
  • 2018 International Congress

    Prevalence and Correlates of Anxiety & Depression in Cervical Dystonia

    M. Al Hussona, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: Our aim was to assess the prevalence and severity of mood disorder in our Cervical Dystonia population attending the botulinum toxin clinic and to…
  • 2018 International Congress

    Higher Levels of Serum Uric Acid Associated with Motor & Non-Motor Symptoms in Early Parkinson’s Disease

    N. Chia, W.L. Au, Z. Lu, X. Huang, S. Ng, S. Acharyya, F. Setiawan, E. Ng, K.Y. Tay, E.K. Tan, L. Tan (Singapore, Singapore)

    Objective: Uric acid (UA) has been shown to be potentially neuroprotective in Parkinson's disease (PD), a progressive neurodegenerative disorder that is clinically characterised by motor…
  • 2018 International Congress

    Utilizing latent class analysis to explore the sleep disturbance subtypes in Parkinson’s disease patients

    H.J. Yang, H.J. Kim, S.J. Kim (Ulsan, Republic of Korea)

    Objective: The aim of this study was to analyze whether distinct sleep disturbance subtypes could be empirically identified in patients with Parkinson’s disease (PD) based…
  • 2018 International Congress

    Sleep, Fatigue and Health-related quality of life in a cohort of Parkinson disease patients

    O. Ojo, N. Okubadejo, O. Odeniyi, N. Osemwegie, O. Oguntunde (Idi-araba, Nigeria)

    Objective: To determine frequencies of non-motor symptoms (NMS) specifically sleep disorders, fatigue and mood disorders in a cohort of Nigerians with PD seen at the…
  • 2018 International Congress

    Exploration of insight competence in Huntington’s disease supplemental to a cognitive debriefing study for the FuRST2.0 rating scale

    R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

    Objective: Evaluate insight of functional impairment in premanifest and early-manifest Huntington’s disease (HD). Background: Following the guidelines of the US Food and Drug Administration Clinical…
  • 2018 International Congress

    Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson’s Disease

    P. Huang, H.Y. Zhou, S.D. Chen (Shanghai, China)

    Objective: We classified Parkinson’s disease (PD) patients into different subtypes and evaluated the correlation between the substantia nigra (SN) echogenicity and disease progression. Background: It…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley